Spontaneous Coronary Artery Dissection National Swiss Registry
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorDr. Sophie Degrauwe
About this trial
Spontaneous coronary artery dissection (SCAD), is an underdiagnosed pathology, affecting predominantly young women without traditional cardiovascular risk factors and is associated with major adverse outcomes including myocardial infarction, cardiac arrest, or death.
Timely diagnosis of SCAD as well as clinical follow-up are of the essence in this pathology associated with major cardiac adverse outcomes. Despite recent improvements in diagnosis and recognition of the importance of SCAD, it remains poorly studied and understood.
In this context, we designed the SwissSCAD registry, a large, observational, prospective, cohort study, to describe the natural history of SCAD, its outcomes and its treatments.
Eligibility criteria
Qualifiers
Subject is ≥18 years of age.
Patient presenting newly diagnosed SCAD or diagnosed with SCAD within the last 5 years.
Subject must be willing to sign a Patient Informed Consent (PIC).
Disqualifiers
Patient unwilling or unable to provide informed consent.
Patients with atherosclerotic or iatrogenic coronary dissection.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
1,000 Participants
are grouped into 2 trial groupsSponsors and collaborators
Dr. Sophie Degrauwe
Lead sponsor
University Hospital, Geneva
Sponsor institution
Source ClinicalTrials.gov